Home » Genome Technology

Cover Story

The Search for New Drugs

Drug discovery no longer belongs solely in the hands of drug companies. Pharmas are partnering with nonprofit and other groups, while academia is striking out on its own.

The Search for New Drugs

Feature Story

  • ChIP Goes Genome-Scale

    Studies of chromatin immunoprecipitation were once slow, tedious affairs. But thanks to microarrays and next-gen sequencers, scientists are beginning to run their ChIP queries across entire genomes.

  • The Changing Face of Biobanks

    As genomics and proteomics become increasingly clinical in nature, the need for excellent sample collections is turning into a major bottleneck to large-scale studies. Repositories are racing to set standards and meet privacy and other concerns in their collections.

  • Biomarkers Take Center Stage

    Researchers sit down with GT to discuss the major challenges — and promises — of biomarker research.

Primer

Markers

Zeitgeist

  • Sampling the Blogs

    Bloggers chat about access to genetic information, the BRCA patents, gender bias in peer review, and the GSK/Pfizer joint venture.

Careers

  • The Job Quest

    Whether you're a first-time job seeker or a veteran, this competitive market means it's even more important to make sure you get everything just right.

Lab Reunion

  • The ABCs of Good Research

    Eric Green expects his postdocs to be capable of solid science — and to be effective writers and communicators, too. Sometimes his best lessons are doled out not in genomic data but with a red pen.

Under One Roof

  • Endless Possibilities

    Vanderbilt's integrative biosystems institute blends engineering and biology, among other disciplines, to answer questions most people can't even ask.

My Take

  • Data Troubles

    Scientist and blogger Keith Robison considers sins of commission and omission of syns.

Brute Force

  • Cloudy With a Chance of HPC

    Not long ago, cloud computing was an emerging trend with plenty of dubious onlookers. Today, it's becoming a viable solution for life science researchers.

Where Are They Now?

In the Clinic

Technology Spotlights

Calendar & Deadlines

Blunt End